Perella Weinberg Partners (PWP)
NASDAQ: PWP · Real-Time Price · USD
22.06
+0.20 (0.91%)
At close: Apr 28, 2026, 4:00 PM EDT
22.26
+0.20 (0.91%)
After-hours: Apr 28, 2026, 4:52 PM EDT

Company Description

Perella Weinberg Partners, an independent advisory firm, provides strategic and financial advice services in the United States, the United Kingdom, and internationally.

It offers advisory services related to strategic and financial decisions, mergers and acquisition execution, shareholder engagement advisory, and financing and capital solutions advice with a focus on restructuring, liability management, capital markets advisory, and private capital placement, as well as underwriting and research services primarily for the energy and related industries.

The company serves public multinational corporations, mid-sized public and private companies, financial sponsors, individual entrepreneurs, private and institutional investors, creditor committees, and government institutions in consumer and retail; energy and energy transition; financial services and FinTech; healthcare; industrials and infrastructure; and technology, telecommunication, and media industries.

Perella Weinberg Partners is headquartered in New York, New York.

Perella Weinberg Partners
Perella Weinberg Partners logo
Country United States
Founded 2006
Industry Capital Markets
Sector Financials
Employees 736
CEO Andrew Bednar

Contact Details

Address:
767 Fifth Avenue
New York, New York 10153
United States
Phone 212 287 3200
Website pwpartners.com

Stock Details

Ticker Symbol PWP
Exchange NASDAQ
Stock Type Common Stock
Share Class Class A Shares
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001777835
CUSIP Number 71367G102
ISIN Number US71367G1022
Employer ID 84-1770732
SIC Code 6199

Key Executives

Name Position
Andrew Bednar J.D. Chief Executive Officer, Partner of New York and Director
Peter Amory Weinberg A.C.A. Co-Founder, Founding Partner and Chairman
Dietrich Becker Partner of London, President and Director
Taylor Reinhardt Executive Director and Head of Investor Relations
Titus W. Leung J.D. Partner for Advisory Business - New York
Michael Grace Partner of Advisory - New York
Daniel Avrutsky Partner
Michele Abrams Managing Director
Christopher Blake Partner of Healthcare Group
Saahil Sajnani Managing Director of New York

Latest SEC Filings

Date Type Title
Apr 13, 2026 8-K Current Report
Apr 10, 2026 ARS Filing
Apr 10, 2026 DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Apr 10, 2026 DEF 14A Other definitive proxy statements
Mar 27, 2026 SCHEDULE 13G/A Filing
Feb 27, 2026 10-K Annual Report
Feb 10, 2026 SCHEDULE 13G/A Filing
Feb 6, 2026 S-8 Securities to be offered to employees in employee benefit plans
Feb 6, 2026 8-K Current Report
Jan 13, 2026 8-K Current Report